US Bancorp’s Qualigen Therapeutics QLGN Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | 
        
          
          
            Change in  Stake  | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 
        
          
      
        2025
         Q2  | $24 | Hold | 
         | 
    |||||
| 
        
          
      
        2025
         Q1  | $25 | Hold | 
         | 
    |||||
| 
        
          
      
        2024
         Q4  | $29 | Sell | 
         | 
    |||||
| 
        
          
      
        2024
         Q3  | $140 | Hold | 
         | 
    |||||
| 
        
          
      
        2024
         Q2  | $142 | Hold | 
         | 
    |||||
| 
        
          
      
        2024
         Q1  | $330 | Hold | 
         | 
    |||||
| 
        
          
      
        2023
         Q4  | $453 | Hold | 
         | 
    |||||
| 
        
          
      
        2023
         Q3  | $832 | Hold | 
         | 
    |||||
| 
        
          
      
        2023
         Q2  | $751 | Hold | 
         | 
    |||||
| 
        
          
      
        2023
         Q1  | $762 | Buy | 
         | 
    |||||
| 
        
          
      
        2022
         Q4  | $486 | Sell | 
         | 
    |||||
| 
        
          
      
        2022
         Q3  | $2K | Hold | 
         | 
    |||||
| 
        
          
      
        2022
         Q2  | $5K | Hold | 
         | 
    |||||
| 
        
          
      
        2022
         Q1  | $5K | Sell | 
         | 
    |||||
| 
        
          
      
        2021
         Q4  | $9K | Sell | 
         | 
    |||||
| 
        
          
      
        2021
         Q3  | $12K | Sell | 
         | 
    |||||
| 
        
          
      
        2021
         Q2  | $20K | Hold | 
         | 
    |||||
| 
        
          
      
        2021
         Q1  | $26K | Hold | 
         | 
    |||||
| 
        
          
      
        2020
         Q4  | $29K | Buy | 
         |